Evidence map›Paper›PMID 24569840›Full record

ArticleAdvanced functional materials2014

Iron Oxide-labeled Collagen Scaffolds for Non-invasive MR Imaging in Tissue Engineering.

Marianne E Mertens, Alina Hermann, Anne Bühren, Leon Olde-Damink, Diana Möckel, Felix Gremse, Josef Ehling, Fabian Kiessling, Twan Lammers

Abstract read
In one paragraph

Article in Advanced functional materials, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. Review
  2. TargetedImmunotherapy advances · 2026
    Review
  3. X-Ray Visible Protein Scaffolds by Bulk Iodination.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  4. Mass Spectrometry Imaging of Biomaterials.Materials (Basel, Switzerland) · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Radiopaque Implantable Biomaterials for Nerve Repair.bioRxiv : the preprint server for biology · 2023
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. In Vivo Imaging of Implanted Hyaluronic Acid Hydrogel Biodegradation.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Marianne E MertensDepartment for Experimental Molecular Imaging University Clinic and Helmholtz Institute for Biomedical Engineering RWTH - Aachen University Pauwelsstrasse 20, 52074 Aachen (Germany).
Alina HermannMatricel GmbH Kaiserstraße 100 52134 Herzogenrath (Germany).
Anne BührenMatricel GmbH Kaiserstraße 100 52134 Herzogenrath (Germany).
Leon Olde-DaminkMatricel GmbH Kaiserstraße 100 52134 Herzogenrath (Germany).
Diana MöckelDepartment for Experimental Molecular Imaging University Clinic and Helmholtz Institute for Biomedical Engineering RWTH - Aachen University Pauwelsstrasse 20, 52074 Aachen (Germany).
Felix GremseDepartment for Experimental Molecular Imaging University Clinic and Helmholtz Institute for Biomedical Engineering RWTH - Aachen University Pauwelsstrasse 20, 52074 Aachen (Germany).
Josef EhlingDepartment for Experimental Molecular Imaging University Clinic and Helmholtz Institute for Biomedical Engineering RWTH - Aachen University Pauwelsstrasse 20, 52074 Aachen (Germany).
Fabian KiesslingDepartment for Experimental Molecular Imaging University Clinic and Helmholtz Institute for Biomedical Engineering RWTH - Aachen University Pauwelsstrasse 20, 52074 Aachen (Germany).
Twan LammersDepartment for Experimental Molecular Imaging University Clinic and Helmholtz Institute for Biomedical Engineering RWTH - Aachen University Pauwelsstrasse 20, 52074 Aachen (Germany); Department of Controlled Drug Delivery MIRA Institute for Biomedical Engineering and Technical Medicine University of Twente PO Box 217, 7500 AE Enschede (The Netherlands).

Funding

European Research Council 309495
6 · The paper itself

Abstract

Non-invasive imaging holds significant potential for implementation in tissue engineering. It can e.g. be used to monitor the localization and function of tissue-engineered implants, as well as their resorption and remodelling. Thus far, however, the vast majority of efforts in this area of research have focused on the use of ultrasmall super-paramagnetic iron oxide (USPIO) nanoparticle-labeled cells, colonizing the scaffolds, to indirectly image the implant material. Reasoning that directly labeling scaffold materials might be more beneficial (enabling imaging also in case of non-cellularized implants), more informative (enabling the non-invasive visualization and quantification of scaffold degradation) and more easy to translate into the clinic (since cell-free materials are less complex from a regulatory point-of-view), we here prepared three different types of USPIO nanoparticles, and incorporated them both passively and actively (via chemical conjugation; during collagen crosslinking) into collagen-based scaffold materials. We furthermore optimized the amount of USPIO incorporated into the scaffolds, correlated the amount of entrapped USPIO with MR signal intensity, showed that the labeled scaffolds are highly biocompatible, demonstrated that scaffold degradation can be visualized using MRI and provided initial proof-of-principle for the in vivo visualization of the scaffolds. Consequently, USPIO-labeled scaffold materials seem to be highly suitable for image-guided tissue engineering applications.

Indexed as

Collagen ScaffoldsImagingIron oxide nanoparticlesMRITissue Engineering

Identifiers

PMID24569840
PMCPMC3837415

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.